Suspension de la négociation par l'OCRCVM - COT Canada NewsWire VANCOUVER, BC, le 15 oct. 2020 VANCOUVER, BC, le 15 oct. 2020 /CNW/ - L'OCRCVM a suspendu la négociation des titres...
IIROC Trading Halt - COT Canada NewsWire VANCOUVER, BC, Oct. 15, 2020 VANCOUVER, BC, Oct. 15, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Cotinga Pharmaceuticals...
L'OCRCVM permet la reprise de la négociation - COT Canada NewsWire VANCOUVER, le 7 nov. 2019 VANCOUVER, le 7 nov. 2019 /CNW/ - Reprise des négociations pour : Société : Cotinga...
IIROC Trading Resumption - COT Canada NewsWire VANCOUVER, Nov. 7, 2019 VANCOUVER, Nov. 7, 2019 /CNW/ - Trading resumes in: Company: Cotinga Pharmaceuticals Inc TSX-Venture Symbol: COT (all...
Suspension de la négociation par l'OCRCVM - COT Canada NewsWire VANCOUVER, le 7 oct. 2019 VANCOUVER, le 7 oct. 2019 /CNW/ - L'OCRCVM a suspendu la négociation des titres suivants :...
IIROC Trading Halt - COT Canada NewsWire VANCOUVER, Oct. 7, 2019 VANCOUVER, Oct. 7, 2019 /CNW/ - The following issues have been halted by IIROC: Company: Cotinga Pharmaceuticals Inc TSX-Venture...
TORONTO and BOSTON, July 18, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 27, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 05, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline...
TORONTO and BOSTON, June 04, 2019 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical stage biopharmaceutical company advancing a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.